Impleo Medical is starting a prospective, randomized, controlled clinical trial. It’s being conducted by gastroenterologists in multiple centers in the U.S. The overall objective of the study is to determine if Impleo’s bulking agent is safe and effective for patients who still have GERD symptoms despite taking medications. The trial is designed to have a one-year follow up with multiple follow-up visits.
If you are interested in participating in the trial or want to know more, please contact us.